Last reviewed · How we verify

Rescue analgesia

Universidade do Porto · FDA-approved active Small molecule

Rescue analgesia refers to supplemental pain relief medication administered on an as-needed basis to manage breakthrough pain in patients already on scheduled analgesics.

Rescue analgesia refers to supplemental pain relief medication administered on an as-needed basis to manage breakthrough pain in patients already on scheduled analgesics. Used for Breakthrough pain in cancer patients, Acute pain episodes in chronic pain conditions.

At a glance

Generic nameRescue analgesia
SponsorUniversidade do Porto
ModalitySmall molecule
Therapeutic areaPain Management
PhaseFDA-approved

Mechanism of action

Rescue analgesia is a therapeutic approach rather than a specific drug entity, typically involving short-acting opioids or other analgesics used to treat acute pain episodes that occur despite baseline pain management. The mechanism depends on the specific agent used (e.g., opioid receptor agonism for opioid-based rescue medications). This strategy is commonly employed in cancer pain management and chronic pain conditions.

Approved indications

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: